1H MR spectroscopy in patients with mesial temporal epilepsy
Jazyk angličtina Země Německo Médium print
Typ dokumentu časopisecké články, práce podpořená grantem, přehledy
PubMed
9951770
DOI
10.1007/bf02592234
Knihovny.cz E-zdroje
- MeSH
- cholin metabolismus MeSH
- epilepsie temporálního laloku diagnóza metabolismus MeSH
- GABA metabolismus MeSH
- glutamin metabolismus MeSH
- hipokampus metabolismus patologie MeSH
- kreatin metabolismus MeSH
- kyselina asparagová analogy a deriváty metabolismus MeSH
- kyselina glutamová metabolismus MeSH
- lidé MeSH
- magnetická rezonanční tomografie metody MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- přehledy MeSH
- Názvy látek
- cholin MeSH
- GABA MeSH
- glutamin MeSH
- kreatin MeSH
- kyselina asparagová MeSH
- kyselina glutamová MeSH
- N-acetylaspartate MeSH Prohlížeč
The study provides a review of the basic examination procedures and results of proton magnetic resonance spectroscopy (1H MRS) in patients suffering from mesial temporal lobe epilepsy (MTLE). The source of seizures in MTLE is most often an epileptogenic focus secondary to hippocampal sclerosis. 1H MRS currently plays an important role in the non-invasive diagnosis of this type of epileptogenic lesion. The decisive 1H MRS parameter characterizing an epileptogenic lesion is a statistically significantly decreased value of N-acetylaspartate levels compared with control values, most often associated with a decrease in the ratios of the intensities of NAA/Cr, NAA/Cho and NAA/(Cr + Cho) signals. Moreover, MRS makes it possible to distinguish bilateral involvement of mesial temporal structures typically associated with a bilateral decrease in the levels of metabolites and/or their ratios. As regards other metabolic compounds which play an important role in the pathobiochemistry of epilepsy, MRS is employed to study the action of gamma-aminobutyric acid (GABA), inositol, lactate, glutamine, and glutamate, the clinical function of which has not been fully clarified as yet. It is in this context that one should consider the application of 1H MRS in evaluating the action of some new anti-epileptic agents affecting excitatory and inhibitory amino acids. There is no doubt that in vivo 1H MRS, along with other imaging methods, has made a significant contribution to the clinical and biochemical description of epileptic seizures and has assumed a prominent position among the techniques of pre-operative examination in epileptic surgery.
Zobrazit více v PubMed
Brain. 1992 Aug;115 ( Pt 4):1001-15 PubMed
Neurology. 1992 Oct;42(10 ):2011-8 PubMed
Ann Neurol. 1992 Feb;31(2):138-46 PubMed
J Neurochem. 1992 Jul;59(1):55-61 PubMed
Epilepsia. 1992 Jul-Aug;33(4):618-23 PubMed
NMR Biomed. 1991 Apr;4(2):47-52 PubMed
NMR Biomed. 1991 Aug;4(4):201-4 PubMed
Nervenarzt. 1991 Dec;62(12):740-4 PubMed
Ann Neurol. 1991 Jul;30(1):31-6 PubMed
AJNR Am J Neuroradiol. 1991 Sep-Oct;12(5):941-7 PubMed
Ann Neurol. 1991 Feb;29(2):175-82 PubMed
Radiology. 1990 May;175(2):423-9 PubMed
Neurology. 1990 Dec;40(12):1869-75 PubMed
Ann Neurol. 1987 Sep;22(3):341-7 PubMed
Psychol Med. 1995 May;25(3):495-503 PubMed
Rev Neurol (Paris). 1995 Jun-Jul;151(6-7):404-9 PubMed
Acta Neurol Scand Suppl. 1995;162:27-30 PubMed
J Magn Reson Imaging. 1995 Jul-Aug;5(4):433-6 PubMed
Magn Reson Med. 1995 May;33(5):595-600 PubMed
Epilepsia. 1995 May;36(5):457-64 PubMed
Epilepsia. 1995 Sep;36(9):946-9 PubMed
Ann Neurol. 1995 Sep;38(3):396-404 PubMed
Neurol Res. 1994 Dec;16(6):481-3 PubMed
Neurology. 1995 Apr;45(4):797-802 PubMed
Am J Psychiatry. 1995 May;152(5):659 PubMed
Neurology. 1995 Jan;45(1):123-6 PubMed
Neuroreport. 1994 Sep 8;5(14):1733-6 PubMed
Ann Neurol. 1995 Feb;37(2):279-81 PubMed
Radiology. 1994 Nov;193(2):465-72 PubMed
Arch Dis Child. 1993 Jul;69(1):104-9 PubMed
Neurology. 1994 Aug;44(8):1411-7 PubMed
Neurosci Biobehav Rev. 1994 Summer;18(2):281-90 PubMed
Neurology. 1993 Mar;43(3 Pt 1):589-94 PubMed
Ann Neurol. 1994 Feb;35(2):211-6 PubMed
Ann Neurol. 1994 Feb;35(2):217-21 PubMed
Epilepsia. 1994 Jan-Feb;35(1):35-41 PubMed
J Cereb Blood Flow Metab. 1994 May;14(3):373-82 PubMed
Neurology. 1993 Jun;43(6):1083-7 PubMed
Neurology. 1994 May;44(5):829-36 PubMed
AJNR Am J Neuroradiol. 1994 Feb;15(2):373-84 PubMed
Brain Res. 1994 Feb 28;638(1-2):53-60 PubMed
Acta Neurol Scand Suppl. 1994;152:116-21 PubMed
Radiology. 1993 Dec;189(3):635-46 PubMed
Ann Neurol. 1993 Dec;34(6):788-94 PubMed
Neurology. 1993 Oct;43(10):2006-10 PubMed
Neurology. 1993 Sep;43(9):1789-93 PubMed
Neurology. 1993 Sep;43(9):1793-9 PubMed
Neurology. 1993 Sep;43(9):1800-5 PubMed
J Neurosci. 1993 Mar;13(3):981-9 PubMed
Neurosurg Clin N Am. 1993 Apr;4(2):199-209 PubMed
Neurology. 1993 Apr;43(4):719-25 PubMed
Proc Natl Acad Sci U S A. 1993 Jun 15;90(12):5662-6 PubMed
Neuroimaging Clin N Am. 1995 Nov;5(4):683-93 PubMed
Ann Neurol. 1996 Jan;39(1):107-13 PubMed
Ann Neurol. 1996 Jan;39(1):95-9 PubMed
Neurology. 1996 May;46(5):1459-63 PubMed
Life Sci. 1996;58(22):1929-35 PubMed
Psychol Med. 1995 Nov;25(6):1201-9 PubMed
Epilepsia. 1996;37 Suppl 1:S10-21 PubMed
Radiology. 1996 May;199(2):381-9 PubMed
Psychiatry Res. 1995 Nov 10;61(4):193-200 PubMed
Magn Reson Imaging. 1995;13(8):1081-93 PubMed
Magn Reson Imaging. 1995;13(8):1095-8 PubMed
Magn Reson Imaging. 1995;13(8):1099-106 PubMed
Magn Reson Imaging. 1995;13(8):1171-3 PubMed
Magn Reson Imaging. 1995;13(8):1175-80 PubMed
Magn Reson Imaging. 1995;13(8):1181-5 PubMed
Magn Reson Imaging. 1995;13(8):1187-91 PubMed
Magn Reson Imaging. 1995;13(8):1193-5 PubMed
Magn Reson Imaging. 1995;13(8):1197-211 PubMed
Magn Reson Imaging. 1995;13(8):1227-31 PubMed
Magn Reson Imaging. 1995;13(8):1233-7 PubMed
AJNR Am J Neuroradiol. 1996 Jan;17(1):1-15 PubMed
Ann Neurol. 1996 Aug;40(2):236-9 PubMed
Neurology. 1996 Apr;46(4):974-7 PubMed
Br J Radiol. 1996 Jan;69(817):15-24 PubMed
Neurology. 1996 Sep;47(3):756-60 PubMed
Schizophr Res. 1996 Oct 18;22(1):5-17 PubMed
J Neurochem. 1996 Dec;67(6):2399-404 PubMed
AJNR Am J Neuroradiol. 1996 Nov-Dec;17(10):1805-10 PubMed
AJNR Am J Neuroradiol. 1996 Nov-Dec;17(10):1811-4 PubMed
AJNR Am J Neuroradiol. 1996 Nov-Dec;17(10):1871-9 PubMed
Magn Reson Med. 1996 Dec;36(6):821-8 PubMed
Neurology. 1996 Dec;47(6):1567-71 PubMed
Magn Reson Med. 1997 Jan;37(1):18-23 PubMed
Ann Neurol. 1997 Jan;41(1):74-81 PubMed
Epilepsia. 1997 Jan;38(1):87-94 PubMed
J Radiol. 1996 Nov;77(11):1095-104 PubMed
Radiology. 1997 Mar;202(3):809-17 PubMed
Epilepsia. 1997 Mar;38(3):338-45 PubMed
Pediatr Neurol. 1997 Feb;16(2):98-104 PubMed
Magn Reson Med. 1997 Apr;37(4):619-23 PubMed
Magn Reson Imaging. 1997;15(2):223-34 PubMed
Neurology. 1997 Apr;48(4):1018-24 PubMed
Brain. 1997 Feb;120 ( Pt 2):339-77 PubMed
NMR Biomed. 1996 Oct;9(7):279-96 PubMed
Schizophr Res. 1996 Mar;19(1):55-9 PubMed
AJNR Am J Neuroradiol. 1997 Jun-Jul;18(6):1131-9 PubMed
Magn Reson Imaging. 1997;15(4):475-8 PubMed
Ann Neurol. 1997 Aug;42(2):194-9 PubMed
Ann Neurol. 1997 Nov;42(5):737-46 PubMed
Neurology. 1997 Dec;49(6):1525-33 PubMed
AJNR Am J Neuroradiol. 1998 Jan;19(1):1-8 PubMed
Magn Reson Imaging Clin N Am. 1998 Feb;6(1):21-9 PubMed
AJR Am J Roentgenol. 1998 Mar;170(3):771-6 PubMed
1H MR spectroscopy in histopathological subgroups of mesial temporal lobe epilepsy